HRMY vs. SUPV
HRMY (Harmony Biosciences Holdings, Inc.) and SUPV (Grupo Supervielle S.A.) are both stocks. HRMY operates in Biotechnology (Healthcare), while SUPV operates in Banks - Regional (Financial Services). Over the past 5 years, HRMY returned 1.50%/yr vs 38.77%/yr for SUPV. At a 0.14 correlation, their price movements are largely independent.
Performance
HRMY vs. SUPV - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, HRMY achieves a -7.91% return, which is significantly lower than SUPV's -6.94% return.
HRMY
- 1D
- -2.10%
- 1M
- 12.03%
- YTD
- -7.91%
- 6M
- -14.93%
- 1Y
- 4.52%
- 3Y*
- -1.66%
- 5Y*
- 1.50%
- 10Y*
- —
SUPV
- 1D
- 1.01%
- 1M
- 39.42%
- YTD
- -6.94%
- 6M
- -0.36%
- 1Y
- -3.17%
- 3Y*
- 63.15%
- 5Y*
- 38.77%
- 10Y*
- 0.23%
HRMY vs. SUPV - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
HRMY Harmony Biosciences Holdings, Inc. | -7.91% | 8.75% | 6.53% | -41.38% | 29.22% | 17.95% | -9.60% |
SUPV Grupo Supervielle S.A. | -6.94% | -20.75% | 281.41% | 87.96% | 11.80% | -6.59% | -16.54% |
Correlation
The correlation between HRMY and SUPV is 0.06, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.06 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.07 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.13 |
Correlation (All Time) Calculated using the full available price history since Aug 19, 2020 | 0.14 |
Fundamentals
HRMY:
$2.03B
SUPV:
$869.13M
HRMY:
$2.48
SUPV:
-ARS 72.13
HRMY:
2.25
SUPV:
1.31
HRMY:
2.22
SUPV:
1.14
HRMY:
$899.11M
SUPV:
ARS 1.02T
HRMY:
$688.25M
SUPV:
ARS 425.09B
HRMY:
$221.74M
SUPV:
-ARS 9.21B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
HRMY vs. SUPV — Risk / Return Rank
HRMY
SUPV
HRMY vs. SUPV - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Harmony Biosciences Holdings, Inc. (HRMY) and Grupo Supervielle S.A. (SUPV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| HRMY | SUPV | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.18 | ||
| Sortino ratioReturn per unit of downside risk | -0.24 | ||
| Omega ratioGain probability vs. loss probability | 1.06 | 1.07 | -0.01 |
| Calmar ratioReturn relative to maximum drawdown | 0.10 | -0.15 | +0.25 |
| Martin ratioReturn relative to average drawdown | 0.18 | -0.32 | +0.50 |
Loading charts...
Drawdowns
HRMY vs. SUPV - Drawdown Comparison
The maximum HRMY drawdown since its inception was -68.48%, smaller than the maximum SUPV drawdown of -95.98%. Use the drawdown chart below to compare losses from any high point for HRMY and SUPV.
Loading charts...
Drawdown Indicators
| HRMY | SUPV | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -68.48% | -95.98% | +27.50% |
Max Drawdown (1Y)Largest decline over 1 year | -34.49% | -59.91% | +25.42% |
Max Drawdown (3Y)Largest decline over 3 years | -50.81% | -75.20% | +24.39% |
Max Drawdown (5Y)Largest decline over 5 years | -68.48% | -75.20% | +6.72% |
Max Drawdown (10Y)Largest decline over 10 years | — | -95.98% | — |
Current DrawdownCurrent decline from peak | -43.42% | -63.26% | +19.84% |
Average DrawdownAverage peak-to-trough decline | -35.27% | -66.96% | +31.69% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 18.73% | 28.53% | -9.80% |
Volatility
HRMY vs. SUPV - Volatility Comparison
The current volatility for Harmony Biosciences Holdings, Inc. (HRMY) is 11.05%, while Grupo Supervielle S.A. (SUPV) has a volatility of 23.01%. This indicates that HRMY experiences smaller price fluctuations and is considered to be less risky than SUPV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| HRMY | SUPV | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.05% | 23.01% | -11.96% |
Volatility (6M)Calculated over the trailing 6-month period | 30.44% | 47.05% | -16.61% |
Volatility (1Y)Calculated over the trailing 1-year period | 42.03% | 95.72% | -53.69% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 50.13% | 71.42% | -21.29% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 52.45% | 72.39% | -19.94% |
Dividends
HRMY vs. SUPV - Dividend Comparison
Neither HRMY nor SUPV has paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
HRMY Harmony Biosciences Holdings, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
SUPV Grupo Supervielle S.A. | 0.00% | 1.71% | 1.12% | 0.00% | 0.71% | 1.36% | 1.79% | 2.03% | 1.32% | 0.30% |
Financials
HRMY vs. SUPV - Financials Comparison
This section allows you to compare key financial metrics between Harmony Biosciences Holdings, Inc. and Grupo Supervielle S.A.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
HRMY vs. SUPV - Profitability Comparison
HRMY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Harmony Biosciences Holdings, Inc. reported a gross profit of 170.88M and revenue of 215.39M. Therefore, the gross margin over that period was 79.3%.
SUPV - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Grupo Supervielle S.A. reported a gross profit of 169.00M and revenue of 387.59M. Therefore, the gross margin over that period was 43.6%.
HRMY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Harmony Biosciences Holdings, Inc. reported an operating income of 37.29M and revenue of 215.39M, resulting in an operating margin of 17.3%.
SUPV - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Grupo Supervielle S.A. reported an operating income of -15.76M and revenue of 387.59M, resulting in an operating margin of -4.1%.
HRMY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Harmony Biosciences Holdings, Inc. reported a net income of 32.49M and revenue of 215.39M, resulting in a net margin of 15.1%.
SUPV - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Grupo Supervielle S.A. reported a net income of -12.03M and revenue of 387.59M, resulting in a net margin of -3.1%.
Frequently Asked Questions
HRMY and SUPV have a correlation of 0.06, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
SUPV has higher volatility (23.01%) compared to HRMY (11.05%). In terms of maximum drawdown, HRMY dropped -68.48% vs SUPV's -95.98%.
HRMY currently has the higher Sharpe Ratio (0.08 vs -0.09), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for HRMY and SUPV
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer